CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-04 | Yocca Frank Chief Scientific Officer | Sale 10b5-1 | −1,067 | $2.64 | $3K | 12,763 |
| 2024-03-15 | O'Neill Vincent See Remarks | Option exercise 10b5-1 | +2,250 | 5,573 | ||
| 2024-03-15 | O'Neill Vincent See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,250 | 6,750 | ||
| 2024-03-15 | Mehta Vimal CEO and President | Option exercise 10b5-1 | +14,000 | 48,832 | ||
| 2024-03-15 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −14,000 | 42,000 | ||
| 2024-03-15 | Steinhart Richard I Chief Financial Officer | Option exercise 10b5-1 | +2,250 | 5,834 | ||
| 2024-03-15 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,250 | 6,750 | ||
| 2024-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +3,000 | 3,000 | ||
| 2024-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units 10b5-1 | +3,000 | 9,000 | ||
| 2024-03-15 | Rodriguez Javier See Remarks | Option exercise 10b5-1 | +2,250 | 8,684 | ||
| 2024-03-15 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −2,250 | 6,750 | ||
| 2024-03-15 | Yocca Frank Chief Scientific Officer | Option exercise 10b5-1 | +2,250 | 13,830 | ||
| 2024-03-15 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,250 | 6,750 | ||
| 2024-03-14 | O'Neill Vincent See Remarks | Option exercise 10b5-1 | +521 | 3,323 | ||
| 2024-03-14 | O'Neill Vincent See Remarks | Option exercise · Restricted Stock Units 10b5-1 | −521 | 4,169 | ||
| 2024-03-14 | Mehta Vimal CEO and President | Option exercise 10b5-1 | +2,610 | 34,832 | ||
| 2024-03-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −2,610 | 20,875 | ||
| 2024-03-14 | Steinhart Richard I Chief Financial Officer | Option exercise 10b5-1 | +521 | 3,584 | ||
| 2024-03-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −521 | 4,169 | ||
| 2024-03-14 | Rodriguez Javier See Remarks | Option exercise 10b5-1 | +521 | 6,434 |
Page 15 of 27 · 521 trades